show episodes
 
Artwork

1
On The Pen: The Weekly Dose

Dave Knapp Man On The Mounjaro

Unsubscribe
Unsubscribe
Weekly+
 
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
  continue reading
 
Artwork

1
The Pound of Cure Weight Loss Podcast

Matthew Weiner, MD and Zoe Schroeder, RD

Unsubscribe
Unsubscribe
Weekly
 
Hosted by obesity specialist Matthew Weiner, MD and dietitian Zoe Schroeder, RD, The Pound of Cure Weight Loss Podcast provides a comprehensive approach to weight loss. We cover nutrition, the new GLP-1 medications and Bariatric Surgery in depth and answer tons of questions from our audience every week.
  continue reading
 
"The Obesity Onion" slices through the complexity of obesity and GLP-1 with a straightforward approach. Your host, Tiffany, cuts the fluff and illustrates what living with obesity truly entails—from navigating GLP-1 treatments and debunking weight loss myths to tackling the mental and emotional challenges head-on. Each episode is an unfiltered look at the realities, backed by science but grounded in everyday experience. If you're seeking practical insights and real stories without the sugarc ...
  continue reading
 
Thanks for tuning in! I'm a medical doctor and Specialist in Endocrinology and Metabolism in Canada, and I'm also certified as a Diplomate of the American Board of Obesity Medicine. Why do I blog and podcast about weight management, obesity, and diabetes? Well, there is a LOT of misinformation out there, so I'm here to provide a resource that you (as a person/patient or as a health care provider) can trust! I bring to you hot topics, new science, and breaking news, with some mythbusting mixe ...
  continue reading
 
This podcast covers a broad range of health topics from an integrative medicine perspective that combines conventional medicine and complementary therapies to promote health and wellness. Most physicians are specialized now, so health can be approached too narrowly, and many factors that contribute to poor health are ignored or overlooked. Rather than chasing symptoms with drugs, Dr. Ban gets to the root of health problems and offers suggestions for achieving optimal health through the least ...
  continue reading
 
Loading …
show series
 
There are currently no medications to treat sleep apnea. Could tirzepatide (Zepbound/Mounjaro) treat sleep apnea along with providing weight loss? Learn more: https://drsue.ca/2024/06/can-tirzepatide-mounjaro-zepbound-treat-obstructive-sleep-apnea/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
Send us a Text Message. On The GLP-1 Pen Book Alerts: https://onthepen.com/emails Gan & Lee (China) https://www.prnewswire.com/news-releases/gan--lee-pharmaceuticals-bi-weekly-twice-a-month-glp-1-receptor-agonist-gzr18-injection-achieved-17-29-weight-loss-at-30-weeks-in-a-phase-iib-clinical-trial-302202575.html Mazdutide (China): https://www.fierce…
  continue reading
 
Episode 34 of The Pound of Cure Weight Loss Podcast is titled, Will Ozempic Make You Go Blind? The title comes from our In the News segment, where we cover an article from The Hill titled, Ozempic/Wegovy May be Linked to Rare Form of Blindness. If you’re taking this medication, this is probably a very scary headline. And, of course, it’s meant to b…
  continue reading
 
Topics: 1. The History Behind the "Lipid Hypothesis" that start in Russian in the early 20th Century that lead to the discovery of HDL (good cholesterol) and LDL (bad cholesterol) and eventually statin medication. 2. The Diet-Heart Hypothesis and the "6 and 7 Countries Studies" that lead to the 1980 "Guidelines for Americans", which lowers fat inta…
  continue reading
 
Once weekly basal (long acting) insulin is now available in Canada - the first country in the world to start using it. Find out more about insulin icodec (Awiqli) here! Learn more: https://drsue.ca/2024/07/once-weekly-insulin-now-available-in-canada/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended …
  continue reading
 
Send us a Text Message. PBM reform in Illinois (tiktok video) https://x.com/ManOnMounjaro/status/1812833885375332394 FTC on PBM https://www.ftc.gov/system/files/ftc_gov/pdf/pharmacy-benefit-managers-staff-report.pdf https://www.ftc.gov/news-events/news/press-releases/2024/07/ftc-releases-interim-staff-report-prescription-drug-middlemen FDA and soci…
  continue reading
 
Send us a Text Message. Dave chats with world renowned obesity expert who consults for the likes of Novo Nordisk! Beverly Tchang, MD is a triple board-certified physician with a focus on obesity medicine. Since 2018, she has been treating patients and training professionals in endocrinology and obesity. Her nationally recognized expertise has led h…
  continue reading
 
Episode 33 of The Pound of Cure Weight Loss Podcast is titled, Do You Have the Obesity Gene? The title comes from our In the News segment, where we dive into an article by CNN titled, Researchers Have Found A ‘Clear Genetic Trigger for Obesity’ that Applies to Some People. According to the University of Exeter, a gene typically responsible for thyr…
  continue reading
 
Send us a Text Message. Ozempic reduces cancer risk: https://www.bloomberg.com/news/articles/2024-07-05/ozempic-may-lower-risk-of-obesity-related-cancers-study-finds Semaglutide correlated with blindness (tiktok video): https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study 15-years as type-2 diabetic results in a 78% chance of …
  continue reading
 
A study just published in JAMA Opthalmology has been a big news topic this week, suggesting an association between semaglutide (Ozempic or Rybelsus for diabetes, Wegovy for weight loss) and nonarteritic anterior ischemic optic neuropathy (NAION), which can cause blindness. What’s the scoop? Learn more: https://drsue.ca/2024/07/can-semaglutide-ozemp…
  continue reading
 
Episode 32 of The Pound of Cure Weight Loss Podcast is titled, Why We Hate Keto. We cover a lot of material in this episode, including Pharmacy Benefit Managers, over-the-counter supplements for weight loss, Keto and the Lion diet, Glp-1’s, and avocado oil, just to name a few. In our In the News segment, we dive into an article from The New York Ti…
  continue reading
 
Send us a Text Message. Get OTP Emails: https://www.onthepen.com/emails Eli Lilly Eli Lilly sent cease and desist letters to providers of research grade GLP-1s Exclusive news from onthepen.com that has not been covered by any other source https://www.onthepen.com/post/generic-versions-of-zepbound-how-recent-news-affects-their-future Him & Hers: Him…
  continue reading
 
Topics: 1. A New JAMA Prospective cohort study said there is no association between multivitamin supplementation and decrease mortality in adults. Multivitamin is linked to higher mortality risk (4%). 2. Demographics of who uses supplements 3. History when and why multivitamins were used by US adults since early 1940's. 4. Approaches to Supplementa…
  continue reading
 
Episode 31 of The Pound of Cure Weight Loss Podcast is titled, Obesity Discrimination is Alive and Well, Just Ask Chris. The title comes from our In the News segment where we talk about an article from The Maine Wire that examines a lawsuit filed against Cigna claiming that obesity is a disability and Cigna’s failure to cover GLP-1 medications cons…
  continue reading
 
Send us a Text Message. Novo Nordisk expansion in the US: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=168528 Generic liraglutide https://www.onthepen.com/post/teva-launches-first-ever-generic-glp-1-a-game-changer-for-diabetes-and-weight-management New Wegovy Coupon: https://www.wegovy.com/coverage-and-savin…
  continue reading
 
Topics: 1. The normal menstrual cycle that women know since their teenage years. What happen when that menstrual cycle changes as they age? 2. The change in menstrual cycle and the interaction among different hormones. Estrogen dominance, high/low cortisol, low androgen, low thyroid functions, etc. 3. Why do most weight gained occurred at this chan…
  continue reading
 
Episode 30 of The Pound of Cure Weight Loss Podcast is titled, GLP-1 Supplement Scams. In our In the News segment, we cover an article in Today titled, Poppi Prebiotic Soda Brand Faces Class-Action Lawsuit Over Gut Health Claims. Poppi is a brand of soda marketed as a prebiotic and this lawsuit is questioning the validity of the claim. In our Patie…
  continue reading
 
Send us a Text Message. PBM Reform Form Letter: Link to the Letter: https://www.onthepen.com/post/pbm-reform-form-letter-for-elected-representatives Express scripts (tiktok video on PBM reform): Link to my video: https://www.youtube.com/watch?v=l0g6RwViOxc Michigan (tiktok video) Link (Madison Muller): https://www.bloomberg.com/news/articles/2024-0…
  continue reading
 
Some people may lose too much muscle with weight loss medication. In preventing or rebuilding lost muscle, which is more important - dietary protein or physical activity? Learn more: https://drsue.ca/2024/06/preventing-or-rebuilding-muscle-loss-from-weight-loss-medication-is-dietary-protein-or-exercise-more-important/ Any medical discussion on this…
  continue reading
 
Episode 29 of The Pound of Cure Weight Loss Podcast is titled, Wegovy for the Long Run. The title comes from our In the News segment where we discuss an article in US News titled, More Studies Support Wegovy's Long-Term Weight-Loss Benefits. This article details the outcomes of the Select trial which showed that long-term use of Wegovy provided con…
  continue reading
 
Topics: 1. An article was talking about lean muscle mass loss with Ozempic/Wegovy (semaglutide) or Mounjaro/Zepbound (Tirzepatide) even though you lose about 30-50% body weight. Using Selective Androgen Receptor Modulator (SARM) to maintain muscle mass by combining with these medications like Ozempic to help to lose fat mass and maintain lean muscl…
  continue reading
 
Send us a Text Message. Eli Lilly's phase 2 SYNERGY-NASH study shows tirzepatide effectively resolves MASH and improves fibrosis, offering hope for millions. Read more here: https://www.onthepen.com/post/tirzepatide-shows-promise-in-treating-mash-key-findings-from-the-synergy-nash-study Support the Show. MY WORK RELIES ON YOUR GENEROSITY, WAYS TO S…
  continue reading
 
Send us a Text Message. Ro.co/supply-tracker FDA shortage update (tiktok video): Link:https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st=c EASL (European Association for the Study of the Liver) 2024 in Milan Italy Link: https://investor.lilly.com/news-releases/news-release-details/lill…
  continue reading
 
Episode 28 of The Pound of Cure Weight Loss Podcast is titled, How a Gastric Bypass Could Ruin Your Life. The title comes from our In the News segment we cover an article in Medscape titled, Alcohol to Blame: Weight Regain After Bariatric Surgery. It should come as no surprise that alcohol consumption could lead to weight gain. What could be surpri…
  continue reading
 
Send us a Text Message. https://ro.co/weight-loss/supply-tracker https://www.youtube.com/watch?v=mL_krAas70k Novo Nordisk Advertising: Novo Nordisk launches new advertising campaign "The Power of Wegovy" This advertisement includes the new indication for reduction of cardiovascular risk For 2023, the #5 advertising spend for a drug was Rybelsus at …
  continue reading
 
Elevated weight can be a cause or contributor to hypertension. Why is it so important to watch your blood pressure if you are on weight management medication? Learn more: https://drsue.ca/2024/06/watching-blood-pressure-on-weight-loss-medication-why-is-this-important/ Any medical discussion on this podcast is intended to be of a general nature only…
  continue reading
 
Send us a Text Message. Zachariah Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health, he joins #OnThePen to talk all things #mounjaro #zepbound #wegovy #ozempic Reitano is the founder of Ro, a telehealth company that has a vision of giving consumers more power over their health. htt…
  continue reading
 
Obesity: are environmental chemicals at the center of the storm? Find out where these chemicals may reside.... even in our nonstick cookware. Eeew. Learn more: https://drsue.ca/2024/05/obesity-are-environmental-chemicals-at-the-center-of-the-storm/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended fo…
  continue reading
 
Join us as we dive in on our most recent episode of the Pound of Cure Weight Loss Podcast titled, Ozempic, baby! Episode 27 kicks off with our In the News segment where we discuss an article by CNN that discusses how GLP-1’s are increasing fertility. This comes as no surprise considering we saw the same results after weight loss surgery. So why do …
  continue reading
 
Send us a Text Message. On The Pen News: https://www.onthepen.com/blog SHOW NOTES: Ozempic study in New England Journal of Medicine: Link: https://www.bloomberg.com/news/articles/2024-05-24/novo-s-ozempic-slashes-risk-of-death-in-kidney-disease-study Compounding (tiktok video) Link: https://www.abc.net.au/news/2024-05-22/compound-pharmacies-banned-…
  continue reading
 
We know that GLP1 medications reduce protein in the urine in people with type 2 diabetes and kidney disease, but no study had ever been done to see whether GLP1 treatment could protect kidney function – until now. Learn more: https://drsue.ca/2024/05/semaglutide-first-glp1-medication-proven-to-provide-kidney-protection/ Any medical discussion on th…
  continue reading
 
Send us a Text Message. In this week’s episode of On The Pen Live, guest Scott Liberto of PlanetScott.com joins to discuss his experience in the Survodutide clinical trial. Survodutide is an investigational dual agonist targeting both the glucagon and GLP-1 receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. This nove…
  continue reading
 
Episode 26 of the Pound of Cure Weight Loss Podcast is titled, Ablation Conflation and Healthcare Inflation. The title comes from our In the news segment where we discuss an article from Forbes about a new bariatric procedure called Gastric Mucosal Ablation. This procedure uses a laser to burn the Fundus Mucosa. Does it work? And, will this procedu…
  continue reading
 
Send us a Text Message. 📧 SIGN UP FOR EMAILS: https://www.onthepen.com/emails 💳 BECOME A MEMBER: Join this channel https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join 📰 SEEKING ALPHA ARTICLE: https://seekingalpha.com/news/4092598-tiktok-restrict-weight-loss-drug-promotion 🎙️PODCAST LINK: https://podcasts.apple.com/us/podcast/on-the-pen-th…
  continue reading
 
We know that GLP-1 receptor agonist medications reduce heart attack and stroke risk in people with diabetes, and in people with obesity. But what happens to risk of cardiovascular events if GLP-1 receptor agonist treatment is stopped? Learn more: https://drsue.ca/2024/05/does-heart-attack-and-stroke-risk-go-up-after-stopping-glp1-receptor-agonists/…
  continue reading
 
Episode 25 of The Pound of Cure Weight Loss podcast is titled, From 369.5 to 19,341: Lynsey’s journey to the top of Mount Kilimanjaro. The title comes from our Patient Story where we talk to Lynsey who came to us at 369.5 pounds. She lost a ton of weight after her gastric bypass but she didn’t stop there. She embraced physical activities that led h…
  continue reading
 
Send us a Text Message. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://www.hellofresh.com/pages/raf_lp11?c=FIH-XR3LF83PJ9QE&utm_campaign=referralinvite&utm_medium=clipboard&utm_source=freebies&utm_invitername…
  continue reading
 
Send us a Text Message. Roche Pharmaceuticals has acquired Carmot Therapeutics along with three obesity and type 2 diabetes candidates: CT-868 / CT-368 / CT-986 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro Hello Fresh Free Box: https://…
  continue reading
 
Episode 24 of The Pound of Cure Weight Loss podcast is titled, Zepbound to happen: More Drug Shortages. The title comes from our Economics of Obesity segment where we discuss the Zepbound shortages and offer strategies that you can use to ride out the shortage. In our In the news segment, we discuss an article from the New York Times titled, The Mi…
  continue reading
 
Topics: 1. Benefits - Weight loss, Cancer Prevention, Improve Non-alcoholic liver disease, Prediabetes/Diabetes and other health illnesses? 2. Cautions - be care of Medications like Diabetes and Blood Pressure Medications, Keto Flu, Stress, Headaches. 3. Stories - Benefits and Cautions from Patients. 75 y/o male who reversed Type 2 Diabetes.…
  continue reading
 
Send us a Text Message. MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.tiktok.com/@manonthemounjaro https://twitter.com/ManOnMounjaro https://instagram.com/manonthemounjaro https://facebook.com/manonthemounjaro #Z…
  continue reading
 
Wegovy (semaglutide for weight management) is now available in Canada! What do you need to know? Learn more: https://drsue.ca/2024/05/semaglutide-2-4mg-wegovy-for-weight-management-now-at-canadian-pharmacies/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is n…
  continue reading
 
Episode 23 of the Pound of Cure Weight Loss Podcast is titled, Big Food, Big Pharma, Big Lies. The title comes from our In the News segment where we discuss an article we found on Yahoo that talks about how big food makers like General Mills are paying social media dietitian influencers to push their products as part of the anti-diet movement. They…
  continue reading
 
Send us a Text Message. Dave Knapp does a deep dive into todays Eli Lilly earnings call. https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024 MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE: https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join Venmo: OnThePen Ca$h App: ManOnMounjaro SOCIAL LINKS https://www.…
  continue reading
 
Send us a Text Message. 1.7 mg of Wegovy is no longer in shortage: Semaglutide: FDA website updated to show 1.7 mg of Wegovy is no longer in shortage Link: https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Semaglutide%20Injection&st=c GNC introduces special section for GLP-1 users: GNC will have special section…
  continue reading
 
As the global shortage of highly effective weight management and diabetes medications (Ozempic, Wegovy, Mounjaro, Zepbound) continues, who should get priority to new starts? Learn more: https://drsue.ca/2024/04/what-is-fair-allocation-of-glp1-based-medications-during-the-global-shortages/ Any medical discussion on this podcast is intended to be of …
  continue reading
 
Episode 22 of The Pound of Cure Weight Loss podcast is titled, Hot Diggity Dog - Costco’s New Weight Loss Program. The name comes from our In the News segment where we talk about how Costco is entering the medical weight loss space. We dive into what this means for GLP-1 access and whether or not patients benefit. In our Patient Story segment, we t…
  continue reading
 
Loading …

Quick Reference Guide